<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33187550</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular brain</Title><ISOAbbreviation>Mol Brain</ISOAbbreviation></Journal><ArticleTitle>Frequency and methylation status of selected retrotransposition competent L1 loci in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>154</StartPage><MedlinePgn>154</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">154</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13041-020-00694-2</ELocationID><Abstract><AbstractText>Long interspersed element-1 (LINE-1/L1) is the only autonomous transposable element in the human genome that currently mobilises in both germline and somatic tissues. Recent studies have identified correlations between altered retrotransposon expression and the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) in a subset of patients. The risk of an individual developing ALS is dependent on an interaction of genetic variants and subsequent modifiers during life. These modifiers could include environmental factors, which can lead to epigenetic and genomic changes, such as somatic mutations, occurring in the neuronal cells that degenerate as the disease develops. There are more than 1 million L1 copies in the human genome today, but only 80-100 L1 loci in the reference genome are considered to be retrotransposition-competent (RC) and an even smaller number of these RC-L1s loci are highly active. We hypothesise that RC-L1s could affect normal cellular function through their mutagenic potential conferred by their ability to retrotranspose in neuronal cells and through DNA damage caused by the endonuclease activity of the L1-encoded ORF2 protein. To investigate whether either an increase in the genomic burden of RC-L1s or epigenetic changes to RC-L1s altering their expression, could play a role in disease development, we chose a set of seven well characterised genomic RC-L1 loci that were reported earlier to be highly active in a cellular L1 retrotransposition reporter assay or serve as major source elements for germline and/or somatic retrotransposition events. Analysis of the insertion allele frequency of five polymorphic RC-L1s, out of the set of seven, for their presence or absence, did not identify an increased number individually or when combined in individuals with the disease. However, we did identify reduced levels of methylation of RC-L1s in the motor cortex of those individuals with both familial and sporadic ALS compared to control brains. The changes to the regulation of the loci encompassing these RC-L1s demonstrated tissue specificity and could be related to the disease process.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Savage</LastName><ForeName>Abigail L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Ana Illera</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bubb</LastName><ForeName>Vivien J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Bradley</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troakes</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alahmady</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koks</LastName><ForeName>Sulev</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schumann</LastName><ForeName>Gerald G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>John P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-3551-7803</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. JQUINN@LIV.AC.UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L016397/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRF_MRF-060-0003-RG-SMITH</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0600974</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SMITH/APR16/847-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>QUINN/APR15/843-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Brain</MedlineTA><NlmUniqueID>101468876</NlmUniqueID><ISSNLinking>1756-6606</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055517">snRNP Core Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="Y">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018392" MajorTopicYN="N">Genomic Imprinting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020084" MajorTopicYN="N">Long Interspersed Nucleotide Elements</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055517" MajorTopicYN="N">snRNP Core Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">LINE-1</Keyword><Keyword MajorTopicYN="N">Methylation</Keyword><Keyword MajorTopicYN="N">Retrotransposition competent</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>14</Day><Hour>5</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33187550</ArticleId><ArticleId IdType="pmc">PMC7666467</ArticleId><ArticleId IdType="doi">10.1186/s13041-020-00694-2</ArticleId><ArticleId IdType="pii">10.1186/s13041-020-00694-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kazazian HH, Jr, Moran JV. Mobile DNA in health and disease. N Engl J Med. 2017;377(4):361&#x2013;370. doi: 10.1056/NEJMra1510092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1510092</ArticleId><ArticleId IdType="pmc">PMC5980640</ArticleId><ArticleId IdType="pubmed">28745987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cost GJ, Feng Q, Jacquier A, Boeke JD. Human L1 element target-primed reverse transcription in vitro. EMBO J. 2002;21(21):5899&#x2013;5910. doi: 10.1093/emboj/cdf592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf592</ArticleId><ArticleId IdType="pmc">PMC131089</ArticleId><ArticleId IdType="pubmed">12411507</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan DD, Korman MH, Jakubczak JL, Eickbush TH. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell. 1993;72(4):595&#x2013;605. doi: 10.1016/0092-8674(93)90078-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90078-5</ArticleId><ArticleId IdType="pubmed">7679954</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Moran JV, Kazazian HH, Jr, Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 1996;87(5):905&#x2013;916. doi: 10.1016/S0092-8674(00)81997-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81997-2</ArticleId><ArticleId IdType="pubmed">8945517</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazina E, Weichenrieder O. Non-LTR retrotransposons encode noncanonical RRM domains in their first open reading frame. Proc Natl Acad Sci U S A. 2009;106(3):731&#x2013;736. doi: 10.1073/pnas.0809964106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809964106</ArticleId><ArticleId IdType="pmc">PMC2630067</ArticleId><ArticleId IdType="pubmed">19139409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias SL, Scott AF, Kazazian HH, Jr, Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science. 1991;254(5039):1808&#x2013;1810. doi: 10.1126/science.1722352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1722352</ArticleId><ArticleId IdType="pubmed">1722352</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH., Jr High frequency retrotransposition in cultured mammalian cells. Cell. 1996;87(5):917&#x2013;927. doi: 10.1016/S0092-8674(00)81998-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81998-4</ArticleId><ArticleId IdType="pubmed">8945518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860&#x2013;921. doi: 10.1038/35057062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35057062</ArticleId><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers JS, Vincent BJ, Udall H, Watkins WS, Morrish TA, Kilroy GE, et al. A comprehensive analysis of recently integrated human Ta L1 elements. Am J Hum Genet. 2002;71(2):312&#x2013;326. doi: 10.1086/341718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341718</ArticleId><ArticleId IdType="pmc">PMC379164</ArticleId><ArticleId IdType="pubmed">12070800</ArticleId></ArticleIdList></Reference><Reference><Citation>Penzkofer T, Jager M, Figlerowicz M, Badge R, Mundlos S, Robinson PN, et al. L1Base 2: more retrotransposition-active LINE-1s, more mammalian genomes. Nucleic Acids Res. 2017;45(D1):D68&#x2013;D73. doi: 10.1093/nar/gkw925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw925</ArticleId><ArticleId IdType="pmc">PMC5210629</ArticleId><ArticleId IdType="pubmed">27924012</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A. 2003;100(9):5280&#x2013;5285. doi: 10.1073/pnas.0831042100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0831042100</ArticleId><ArticleId IdType="pmc">PMC154336</ArticleId><ArticleId IdType="pubmed">12682288</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodier JL, Ostertag EM, Kazazian HH., Jr Transduction of 3'-flanking sequences is common in L1 retrotransposition. Hum Mol Genet. 2000;9(4):653&#x2013;657. doi: 10.1093/hmg/9.4.653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.4.653</ArticleId><ArticleId IdType="pubmed">10699189</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran JV. Human L1 retrotransposition: insights and peculiarities learned from a cultured cell retrotransposition assay. Genetica. 1999;107(1&#x2013;3):39&#x2013;51. doi: 10.1023/A:1004035023356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1004035023356</ArticleId><ArticleId IdType="pubmed">10952196</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, et al. LINE-1 retrotransposition activity in human genomes. Cell. 2010;141(7):1159&#x2013;1170. doi: 10.1016/j.cell.2010.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.05.021</ArticleId><ArticleId IdType="pmc">PMC3013285</ArticleId><ArticleId IdType="pubmed">20602998</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner EJ, Lam VK, Harris DN, Chuang NT, Scott EC, Pittard WS, et al. The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Res. 2017;27(11):1916&#x2013;1929. doi: 10.1101/gr.218032.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.218032.116</ArticleId><ArticleId IdType="pmc">PMC5668948</ArticleId><ArticleId IdType="pubmed">28855259</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane CM, Collier P, Rahbari R, Beck CR, Wagstaff JF, Igoe S, et al. Transduction-specific ATLAS reveals a cohort of highly active L1 retrotransposons in human populations. Hum Mutat. 2013;34(7):974&#x2013;985. doi: 10.1002/humu.22327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22327</ArticleId><ArticleId IdType="pmc">PMC3880804</ArticleId><ArticleId IdType="pubmed">23553801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 2014;345(6196):1251343. doi: 10.1126/science.1251343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1251343</ArticleId><ArticleId IdType="pmc">PMC4380235</ArticleId><ArticleId IdType="pubmed">25082706</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodier JL, Kazazian HH., Jr Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell. 2008;135(1):23&#x2013;35. doi: 10.1016/j.cell.2008.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.09.022</ArticleId><ArticleId IdType="pubmed">18854152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata K, Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene. 1997;189(2):227&#x2013;234. doi: 10.1016/S0378-1119(96)00856-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(96)00856-6</ArticleId><ArticleId IdType="pubmed">9168132</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Zingler N, Schumann G, Stratling WH. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res. 2001;29(21):4493&#x2013;4501. doi: 10.1093/nar/29.21.4493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.21.4493</ArticleId><ArticleId IdType="pmc">PMC60185</ArticleId><ArticleId IdType="pubmed">11691937</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann GG, Fuchs NV, Tristan-Ramos P, Sebe A, Ivics Z, Heras SR. The impact of transposable element activity on therapeutically relevant human stem cells. Mob DNA. 2019;10:9. doi: 10.1186/s13100-019-0151-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-019-0151-x</ArticleId><ArticleId IdType="pmc">PMC6408843</ArticleId><ArticleId IdType="pubmed">30899334</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Perez JL, Widmann TJ, Adams IR. The impact of transposable elements on mammalian development. Development. 2016;143(22):4101&#x2013;4114. doi: 10.1242/dev.132639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.132639</ArticleId><ArticleId IdType="pmc">PMC5830075</ArticleId><ArticleId IdType="pubmed">27875251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodea GO, McKelvey EGZ, Faulkner GJ. Retrotransposon-induced mosaicism in the neural genome. Open Biol. 2018 doi: 10.1098/rsob.180074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180074</ArticleId><ArticleId IdType="pmc">PMC6070720</ArticleId><ArticleId IdType="pubmed">30021882</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns KH. Transposable elements in cancer. Nat Rev Cancer. 2017;17(7):415&#x2013;424. doi: 10.1038/nrc.2017.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2017.35</ArticleId><ArticleId IdType="pubmed">28642606</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet. 2011;12:187&#x2013;215. doi: 10.1146/annurev-genom-082509-141802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-082509-141802</ArticleId><ArticleId IdType="pmc">PMC4124830</ArticleId><ArticleId IdType="pubmed">21801021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancks DC, Kazazian HH., Jr Roles for retrotransposon insertions in human disease. Mob DNA. 2016;7:9. doi: 10.1186/s13100-016-0065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-016-0065-9</ArticleId><ArticleId IdType="pmc">PMC4859970</ArticleId><ArticleId IdType="pubmed">27158268</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott EC, Gardner EJ, Masood A, Chuang NT, Vertino PM, Devine SE. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Res. 2016;26(6):745&#x2013;755. doi: 10.1101/gr.201814.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.201814.115</ArticleId><ArticleId IdType="pmc">PMC4889970</ArticleId><ArticleId IdType="pubmed">27197217</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992;52(3):643&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">1310068</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulkner GJ, Billon V. L1 retrotransposition in the soma: a field jumping ahead. Mob DNA. 2018;9:22. doi: 10.1186/s13100-018-0128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-018-0128-1</ArticleId><ArticleId IdType="pmc">PMC6035798</ArticleId><ArticleId IdType="pubmed">30002735</ArticleId></ArticleIdList></Reference><Reference><Citation>Erwin JA, Marchetto MC, Gage FH. Mobile DNA elements in the generation of diversity and complexity in the brain. Nat Rev Neurosci. 2014;15(8):497&#x2013;506. doi: 10.1038/nrn3730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3730</ArticleId><ArticleId IdType="pmc">PMC4443810</ArticleId><ArticleId IdType="pubmed">25005482</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Orrell RW. Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull. 2016;119(1):87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36(20):2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage AL, Schumann GG, Breen G, Bubb VJ, Al-Chalabi A, Quinn JP. Retrotransposons in the development and progression of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(3):284&#x2013;293. doi: 10.1136/jnnp-2018-319210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319210</ArticleId><ArticleId IdType="pmc">PMC6518469</ArticleId><ArticleId IdType="pubmed">30305322</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotzl JK, Lang CM, Haass C, Capell A. Impaired protein degradation in FTLD and related disorders. Ageing Res Rev. 2016;32:122&#x2013;139. doi: 10.1016/j.arr.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.04.008</ArticleId><ArticleId IdType="pubmed">27166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29(5):1164&#x2013;77e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L, Chatterjee N, Borges-Monroy R, Hearn S, Liao WW, Morrill K, et al. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13(3):e1006635. doi: 10.1371/journal.pgen.1006635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Jin Y, Prazak L, Hammell M, Dubnau J. Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS ONE. 2012;7(9):e44099. doi: 10.1371/journal.pone.0044099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044099</ArticleId><ArticleId IdType="pmc">PMC3434193</ArticleId><ArticleId IdType="pubmed">22957047</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GC, Sanchez L, Schaughency PM, Rubio-Roldan A, Choi JA, Planet E, et al. Properties of LINE-1 proteins and repeat element expression in the context of amyotrophic lateral sclerosis. Mob DNA. 2018;9:35. doi: 10.1186/s13100-018-0138-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-018-0138-z</ArticleId><ArticleId IdType="pmc">PMC6295051</ArticleId><ArticleId IdType="pubmed">30564290</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Gonzales PK, Cook CN, Gendron TF, Daughrity LM, Song Y, et al. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum Mol Genet. 2017;26(17):3421&#x2013;3431. doi: 10.1093/hmg/ddx233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx233</ArticleId><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB. Loss of nuclear TDP-43 Is associated with decondensation of LINE retrotransposons. Cell Rep. 2019;27(5):1409&#x2013;21 e6. doi: 10.1016/j.celrep.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouha B, Meischl C, Ostertag E, de Boer M, Zhang Y, Neijens H, et al. Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet. 2002;71(2):327&#x2013;336. doi: 10.1086/341722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341722</ArticleId><ArticleId IdType="pmc">PMC379165</ArticleId><ArticleId IdType="pubmed">12094329</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith L, Cupid BC, Dickie BG, Al-Chalabi A, Morrison KE, Shaw CE, et al. Establishing the UK DNA Bank for motor neuron disease (MND) BMC Genet. 2015;16:84. doi: 10.1186/s12863-015-0236-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12863-015-0236-6</ArticleId><ArticleId IdType="pmc">PMC4501191</ArticleId><ArticleId IdType="pubmed">26170009</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Min EALSSC Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2018;26(10):1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, Kenna KP, van den Berg LH, Veldink JH, et al. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(5&#x2013;6):432&#x2013;440. doi: 10.1080/21678421.2019.1606244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1606244</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, et al. Many human L1 elements are capable of retrotransposition. Nat Genet. 1997;16(1):37&#x2013;43. doi: 10.1038/ng0597-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0597-37</ArticleId><ArticleId IdType="pubmed">9140393</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559&#x2013;575. doi: 10.1086/519795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/519795</ArticleId><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52(3):306&#x2013;319. doi: 10.1038/s41588-019-0562-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0562-0</ArticleId><ArticleId IdType="pmc">PMC7058536</ArticleId><ArticleId IdType="pubmed">32024998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Mun S, Meyer TJ, Han K. High levels of sequence diversity in the 5' UTRs of human-specific L1 elements. Comp Funct Genomics. 2012;2012:129416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286893</ArticleId><ArticleId IdType="pubmed">22400009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Luque FJ, Kempen MHC, Gerdes P, Vargas-Landin DB, Richardson SR, Troskie RL, et al. LINE-1 evasion of epigenetic repression in humans. Mol Cell. 2019;75(3):590&#x2013;60412. doi: 10.1016/j.molcel.2019.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.05.024</ArticleId><ArticleId IdType="pubmed">31230816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestor TH, Bourc'his D. Transposon silencing and imprint establishment in mammalian germ cells. Cold Spring Harb Symp Quant Biol. 2004;69:381&#x2013;387. doi: 10.1101/sqb.2004.69.381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2004.69.381</ArticleId><ArticleId IdType="pubmed">16117671</ArticleId></ArticleIdList></Reference><Reference><Citation>Thayer RE, Singer MF, Fanning TG. Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1-encoded protein. Gene. 1993;133(2):273&#x2013;277. doi: 10.1016/0378-1119(93)90651-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-1119(93)90651-I</ArticleId><ArticleId IdType="pubmed">7693554</ArticleId></ArticleIdList></Reference><Reference><Citation>Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature. 2010;468(7322):443&#x2013;446. doi: 10.1038/nature09544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09544</ArticleId><ArticleId IdType="pmc">PMC3059197</ArticleId><ArticleId IdType="pubmed">21085180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasior SL, Wakeman TP, Xu B, Deininger PL. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol. 2006;357(5):1383&#x2013;1393. doi: 10.1016/j.jmb.2006.01.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.01.089</ArticleId><ArticleId IdType="pmc">PMC4136747</ArticleId><ArticleId IdType="pubmed">16490214</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppede F, Migliore L. DNA damage in neurodegenerative diseases. Mutat Res. 2015;776:84&#x2013;97. doi: 10.1016/j.mrfmmm.2014.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2014.11.010</ArticleId><ArticleId IdType="pubmed">26255941</ArticleId></ArticleIdList></Reference><Reference><Citation>Penndorf D, Witte OW, Kretz A. DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen Res. 2018;13(2):173&#x2013;180. doi: 10.4103/1673-5374.226377.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.226377</ArticleId><ArticleId IdType="pmc">PMC5879878</ArticleId><ArticleId IdType="pubmed">29557356</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas CA, Tejwani L, Trujillo CA, Negraes PD, Herai RH, Mesci P, et al. Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation. Cell Stem Cell. 2017;21(3):319&#x2013;31 e8. doi: 10.1016/j.stem.2017.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2017.07.009</ArticleId><ArticleId IdType="pmc">PMC5591075</ArticleId><ArticleId IdType="pubmed">28803918</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh A, Macia A, Muotri AR. transposable elements, inflammation, and neurological disease. Front Neurol. 2019;10:894. doi: 10.3389/fneur.2019.00894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00894</ArticleId><ArticleId IdType="pmc">PMC6710400</ArticleId><ArticleId IdType="pubmed">31481926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Meyzer C, Bouazza N, Hully M, Boddaert N, Semeraro M, et al. Reverse-transcriptase Inhibitors in the Aicardi&#x2013;Goutieres Syndrome. N Engl J Med. 2018;379(23):2275&#x2013;2277. doi: 10.1056/NEJMc1810983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1810983</ArticleId><ArticleId IdType="pubmed">30566312</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019;566(7742):73&#x2013;78. doi: 10.1038/s41586-018-0784-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0784-9</ArticleId><ArticleId IdType="pmc">PMC6519963</ArticleId><ArticleId IdType="pubmed">30728521</ArticleId></ArticleIdList></Reference><Reference><Citation>Coufal NG, Garcia-Perez JL, Peng GE, Marchetto MC, Muotri AR, Mu Y, et al. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci U S A. 2011;108(51):20382&#x2013;20387. doi: 10.1073/pnas.1100273108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100273108</ArticleId><ArticleId IdType="pmc">PMC3251057</ArticleId><ArticleId IdType="pubmed">22159035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mazzini L, D'Alfonso S, Corrado L, Canosa A, Moglia C, et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology. 2018;91(7):e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>